Victory Capital Management Inc Mirum Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$27.14 - $34.93 $546,056 - $702,791	20,120 New	20,120 $593,000
Q3 2022 Nov 02, 2022	BUY	$19.98 - $29.44 $12.8 Million - $18.9 Million	641,804 Added 1221.09%	694,364 $14.6 Million
Q2 2022 Aug 01, 2022	BUY	$18.42 - $27.5 $59,128 - $88,275	3,210 Added 6.5%	52,560 $1.02 Million
Q1 2022 May 04, 2022	BUY	$15.5 - $23.93 $764,925 - $1.18 Million	49,350 New	49,350 $1.09 Million
Q2 2020 Aug 07, 2020	SELL	$11.51 - $20.97 $22,778 - $41,499	-1,979 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$9.38 - $23.79 $422 - $1,070	-45 Reduced 2.22%	1,979 $28,000
Q4 2019 Feb 04, 2020	BUY	$6.84 - $25.9 $13,844 - $52,421	2,024 New	2,024 $32,000

196

54.2M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.88B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.